Drug Discovery is Not Black and White—Why Should Your Studies Be?

Medical imaging is a powerful tool that allows for in vivo and ex vivo quantification of various endpoints which can aid in oncology research and drug discovery. With a myriad of imaging options, how do you know which method is the most appropriate for your needs? The purpose of this blog is to bring clarity […]

Quantifying in vivo Biodistribution and Kinetics of Your Biologic or Nanomaterial

With the ability to provide non-invasive, three dimensional, longitudinal, and quantitative data—PET, SPECT, and fluorescence imaging (FMT) enable translational imaging of: Biodistribution Targeting Kinetics Clearance Pathways In vivo biodistribution imaging applications are now critical assays for biologics characterization for discovery screening, lead candidate selection/optimization and safety. At MI Bioresearch (MI) we combine highly sensitive PET, SPECT, […]

Advancing Discovery and Development of Biologics Through Non-Invasive Biodistribution Imaging

With the ability to provide non-invasive, three dimensional, and quantitative data; PET, SPECT, and fluorescence imaging (FMT) enable translational imaging of biodistribution, molecular and cellular targeting, competitive binding and PK/PD. These imaging applications have become critical assays for biologics characterization for discovery screening, lead candidate selection, optimization and safety. The use of imaging-based biodistribution applications […]